Logo image of AVR

ANTERIS TECHNOLOGIES GLOBAL (AVR) Stock Fundamental Analysis

NASDAQ:AVR - US03675P1021 - Common Stock

3.78 USD
+0.08 (+2.16%)
Last: 8/26/2025, 8:15:56 PM
Fundamental Rating

2

AVR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While AVR seems to be doing ok healthwise, there are quite some concerns on its profitability. AVR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AVR had negative earnings in the past year.
AVR Yearly Net Income VS EBIT VS OCF VS FCFAVR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20M -40M -60M

1.2 Ratios

AVR has a worse Return On Assets (-210.47%) than 93.51% of its industry peers.
AVR has a Return On Equity of -343.90%. This is amonst the worse of the industry: AVR underperforms 81.08% of its industry peers.
Industry RankSector Rank
ROA -210.47%
ROE -343.9%
ROIC N/A
ROA(3y)-145.5%
ROA(5y)N/A
ROE(3y)-232.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AVR Yearly ROA, ROE, ROICAVR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -100 -200 -300

1.3 Margins

AVR has a Gross Margin of 59.40%. This is comparable to the rest of the industry: AVR outperforms 58.92% of its industry peers.
AVR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AVR Yearly Profit, Operating, Gross MarginsAVR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

4

2. Health

2.1 Basic Checks

AVR does not have a ROIC to compare to the WACC, probably because it is not profitable.
AVR has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for AVR has been reduced compared to a year ago.
AVR Yearly Shares OutstandingAVR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
AVR Yearly Total Debt VS Total AssetsAVR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -12.30, we must say that AVR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -12.30, AVR is doing worse than 82.16% of the companies in the same industry.
AVR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of AVR (0.00) is better than 70.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.3
ROIC/WACCN/A
WACC8.9%
AVR Yearly LT Debt VS Equity VS FCFAVR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

AVR has a Current Ratio of 2.41. This indicates that AVR is financially healthy and has no problem in meeting its short term obligations.
AVR has a Current ratio (2.41) which is in line with its industry peers.
A Quick Ratio of 2.38 indicates that AVR has no problem at all paying its short term obligations.
With a Quick ratio value of 2.38, AVR perfoms like the industry average, outperforming 57.84% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.41
Quick Ratio 2.38
AVR Yearly Current Assets VS Current LiabilitesAVR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for AVR have decreased strongly by -65.77% in the last year.
The Revenue has decreased by -1.16% in the past year.
EPS 1Y (TTM)-65.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-1.16%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, AVR will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.75% on average per year.
Based on estimates for the next years, AVR will show a very strong growth in Revenue. The Revenue will grow by 36.88% on average per year.
EPS Next Y19.52%
EPS Next 2Y14.75%
EPS Next 3Y11.75%
EPS Next 5YN/A
Revenue Next Year5.99%
Revenue Next 2Y93.05%
Revenue Next 3Y36.88%
Revenue Next 5YN/A

3.3 Evolution

AVR Yearly Revenue VS EstimatesAVR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
AVR Yearly EPS VS EstimatesAVR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AVR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AVR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVR Price Earnings VS Forward Price EarningsAVR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVR Per share dataAVR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.75%
EPS Next 3Y11.75%

More info and screens

0

5. Dividend

5.1 Amount

AVR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANTERIS TECHNOLOGIES GLOBAL

NASDAQ:AVR (8/26/2025, 8:15:56 PM)

3.78

+0.08 (+2.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)12-09 2025-12-09
Inst Owners57.36%
Inst Owner Change-19.36%
Ins Owners0.21%
Ins Owner Change0%
Market Cap136.31M
Analysts80
Price Target16.83 (345.24%)
Short Float %2.46%
Short Ratio3.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-17.64%
Min EPS beat(2)-27.6%
Max EPS beat(2)-7.67%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)20.17%
Min Revenue beat(2)17.96%
Max Revenue beat(2)22.38%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-9.87%
EPS NQ rev (3m)-32.18%
EPS NY rev (1m)-9.64%
EPS NY rev (3m)-26.68%
Revenue NQ rev (1m)-52%
Revenue NQ rev (3m)-52%
Revenue NY rev (1m)-13.08%
Revenue NY rev (3m)-10.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 54.98
P/FCF N/A
P/OCF N/A
P/B 5.58
P/tB 5.61
EV/EBITDA N/A
EPS(TTM)-2.33
EYN/A
EPS(NY)-2.01
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.07
BVpS0.68
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -210.47%
ROE -343.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.4%
FCFM N/A
ROA(3y)-145.5%
ROA(5y)N/A
ROE(3y)-232.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.41
Quick Ratio 2.38
Altman-Z -12.3
F-ScoreN/A
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)191.13%
Cap/Depr(5y)N/A
Cap/Sales(3y)74.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y19.52%
EPS Next 2Y14.75%
EPS Next 3Y11.75%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.16%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year5.99%
Revenue Next 2Y93.05%
Revenue Next 3Y36.88%
Revenue Next 5YN/A
EBIT growth 1Y-64.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5.72%
EBIT Next 3Y4.8%
EBIT Next 5YN/A
FCF growth 1Y-71.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-76.84%
OCF growth 3YN/A
OCF growth 5YN/A